NASDAQ
Oncotelic Therapeutics, Inc. (OTLC) has a free cash flow growth of -43707978.98% as of Friday, May 29, 2026. This represents a 52236483.67% decrease compared to its 12-month average of -83.67%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.